Indivior PLC (LON: INDV)
London
· Delayed Price · Currency is GBP · Price in GBX
947.00
+32.50 (3.55%)
Dec 23, 2024, 4:35 PM BST
Indivior Employees
Indivior had 1,164 employees as of December 31, 2023. The number of employees increased by 236 or 25.43% compared to the previous year.
Employees
1,164
Change (1Y)
236
Growth (1Y)
25.43%
Revenue / Employee
881.89K GBP
Profits / Employee
-2.24K GBP
Market Cap
1.15B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca PLC | 89,900 |
GSK plc | 70,212 |
Haleon plc | 25,408 |
Smith & Nephew plc | 18,452 |
ConvaTec Group PLC | 10,136 |
Hikma Pharmaceuticals PLC | 9,100 |
Oxford Nanopore Technologies plc | 1,238 |
Animalcare Group plc | 226 |
Indivior News
- 5 days ago - Indivior CFO steps down from board after discussions with Oaktree Capital - Seeking Alpha
- 6 days ago - BUSINESS LIVE: Wage growth accelerates; Britvic takeover cleared; Capita to cut more staff - This is Money
- 4 weeks ago - Indivior PLC (INDV) Trading 3.1% Higher on Nov 19 - GuruFocus
- 4 weeks ago - Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024 - PRNewsWire
- 5 weeks ago - SCOPIA CAPITAL MANAGEMENT LP Adjusts Stake in Indivior PLC - GuruFocus
- 6 weeks ago - Indivior jumps amid investor letter, takeover speculation (update) - Seeking Alpha
- 6 weeks ago - Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior - PRNewsWire
- 7 weeks ago - Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month - PRNewsWire